Patient Preference Clinical Trial
Official title:
Mixed-method Study to Evaluate Acceptability, Perceived Toxicity, Preference and Health-related Quality of Life Among HIV Patients Switching to a Dual Therapy Such as the Dovato Regimen
HIV Treatment simplification strategies that involve switching cART regimens from four or three antiretrovirals to two in virologically suppressed patients living with HIV are now available in order to reduce long-term toxicity and enhance treatment adherence. Dolutegravir is a second-generation integrase strand transfer inhibitor (INSTI) with noticeable advantages, including a high genetic barrier to drug resistance, once-daily dosing and lower risk of drug-drug interactions because this agent does not inhibit or induce cytochrome P450 isoenzymes or P-glycoprotein transporters. Dolutegravir is generally well tolerated and the INSTI class is considered to be more "metabolically friendly" compared with other drug classes such as protease inhibitors (PIs). Thus, the combination of dolutegravir plus a second active agent is a particularly inviting option for maintenance treatment and research in this area is evolving. However, though safety and efficacy of dolutegravir are well known, there is no study evaluating patient-reported outcomes (PROs), i.e. subjective and self-reported measures of the patient's health perception. In an era of the efficacy of HIV regimens are more and more comparable, the main discriminant criteria to choose the best treatment option are now adherence and self-reported measures of a patient's health - termed "patient-reported outcomes" (PROs). The study, based on a mixed methodology, include a qualitative part and a quantitative part. The qualitative study will explore patients' and health care professionals' perceptions, knowledge, and representations of triple or quadruple and dual therapies and detect the degree of agreement or disagreement between patients' and practitioners' perspectives. The quantitative study's main objective is to measure the Dovato regimen's impact on a patient's perception (Patient-Reported Outcomes - PRO) on acceptability, toxicity, preference, and Health-Related Quality of Life (HRQL). PRO are collected through self-administered questionnaires at D0 (when the patient switch treatment), M1 and M6.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06002113 -
Eliciting Informed Goals of Care in Elderly Patients
|
N/A | |
| Recruiting |
NCT04549935 -
The PRIME Study: A Randomized, Controlled, Prospective Study
|
Phase 4 | |
| Withdrawn |
NCT04625842 -
Focus Group Interview Study on Patient Experiences and Satisfaction
|
N/A | |
| Completed |
NCT04153266 -
Oral Epithelial Dysplasia Informational Needs Questionnaire
|
||
| Completed |
NCT05618912 -
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
|
N/A | |
| Recruiting |
NCT04205916 -
A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery
|
Phase 4 | |
| Withdrawn |
NCT05607238 -
Patient Perspective Midline Catheter in the Emergency Department
|
N/A | |
| Completed |
NCT04503434 -
Patients' Experiences in a Medicalized Hotel for COVID-19 Acute Care Support
|
||
| Not yet recruiting |
NCT05835635 -
Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine
|
||
| Completed |
NCT05838313 -
Should I Have an Elective Induction?
|
N/A | |
| Active, not recruiting |
NCT02975635 -
Patients' Preferences for Repair Versus Replacement Restorations
|
||
| Active, not recruiting |
NCT05910164 -
Patient Preference Between a Prefilled Syringe or a Prefilled Pen Device for Administration of Pegfilgrastim
|
||
| Recruiting |
NCT04400669 -
The Effect of Mechanical Bowel Preparation Prior to Gynaecological Laparoscopic Surgeries on the Surgical Conditions
|
N/A | |
| Completed |
NCT05749991 -
Efficacy and Retention of Sealants Placement Using Two Isolation Systems
|
N/A | |
| Active, not recruiting |
NCT03118323 -
Patients' Willingness-to-pay of Endodontic Treatment
|
||
| Active, not recruiting |
NCT05284591 -
Non-interventional Study to Evaluate Patient and Healthcare Provider Satisfaction of Daratumumab Use in the Treatment of First-line Daratumumab, Lenalidomide, Dexamethasone (DRd) Multiple Myeloma Patients in Germany Depending on Application Route (sc or iv)
|
||
| Recruiting |
NCT05236218 -
To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).
|
||
| Completed |
NCT05999279 -
Patient Preferences With Pharmaceutical Care: In-person Versus Digital Health
|
||
| Completed |
NCT02995369 -
DryShield vs Cotton Roll Isolation During Sealants Placement: Efficiency and Patient Preference
|
N/A | |
| Completed |
NCT01131715 -
Pharmacist Follow-up, a Qualitative Study of Patient Experience
|